Bio-Rad Laboratories (BIO) News Today $251.16 -5.29 (-2.06%) As of 03:58 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Bio-Rad Laboratories Q4 Earnings TranscriptMarch 4 at 7:10 AM | marketbeat.comMarathon Asset Management Ltd Trims Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)Marathon Asset Management Ltd cut its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 6.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 67,127 shares of the medical research company's stock afMarch 3 at 6:52 AM | marketbeat.comFisher Asset Management LLC Grows Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)Fisher Asset Management LLC lifted its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 15.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 106,871 shares of the medical researchMarch 3 at 4:30 AM | marketbeat.comProficio Capital Partners LLC Invests $9.82 Million in Bio-Rad Laboratories, Inc. (NYSE:BIO)Proficio Capital Partners LLC bought a new stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 29,894 shares of the medical researchMarch 3 at 4:02 AM | marketbeat.comBank of New York Mellon Corp Trims Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)Bank of New York Mellon Corp reduced its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 0.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 267,306 shares of the medical research company's stock after sellingMarch 3 at 3:37 AM | marketbeat.comAsahi Life Asset Management CO. LTD. Invests $350,000 in Bio-Rad Laboratories, Inc. (NYSE:BIO)Asahi Life Asset Management CO. LTD. purchased a new stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 1,065 shares ofMarch 2 at 6:49 AM | marketbeat.comBio-Rad Laboratories (NYSE:BIO) Sets New 12-Month Low - Here's WhyBio-Rad Laboratories (NYSE:BIO) Reaches New 12-Month Low - Here's WhyMarch 1 at 9:31 PM | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Stock Holdings Lessened by Hosking Partners LLPHosking Partners LLP reduced its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 11.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 54,992 shares of the medical research company's stock after selling 7,118 shaMarch 1 at 6:50 AM | marketbeat.comNew York State Common Retirement Fund Sells 1,000 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)New York State Common Retirement Fund lowered its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 8.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 11,075 shares of the medical research coMarch 1 at 3:26 AM | marketbeat.comFjarde AP Fonden Fourth Swedish National Pension Fund Has $1.14 Million Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)Fjarde AP Fonden Fourth Swedish National Pension Fund grew its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 52.6% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,480 shares of the medical research companyFebruary 27, 2025 | marketbeat.comUniversity spin-out Afynia secures $5M seed to commercialize its microRNA panel test for endometriosisFebruary 26, 2025 | msn.comVeritas Asset Management LLP Sells 109,652 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Veritas Asset Management LLP decreased its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 10.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 976,827 shares of the mediFebruary 25, 2025 | marketbeat.comBlackhawk Capital Partners LLC. Increases Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)Blackhawk Capital Partners LLC. increased its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 190.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,176 shares ofFebruary 25, 2025 | marketbeat.comAnalysts Set Bio-Rad Laboratories, Inc. (NYSE:BIO) Price Target at $395.20February 25, 2025 | americanbankingnews.comBio-Rad Laboratories, Inc. (NYSE:BIO) Receives Consensus Rating of "Moderate Buy" from BrokeragesShares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Get Free Report) have received an average rating of "Moderate Buy" from the five brokerages that are presently covering the stock, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation and three have issued a buy recomFebruary 22, 2025 | marketbeat.comBio-Rad Laboratories Updates on Sartorius InvestmentFebruary 21, 2025 | tipranks.comPrincipal Securities Inc. Raises Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)Principal Securities Inc. boosted its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 1,501.1% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 2,994 shares of the medical research company's stock after buying an additionaFebruary 20, 2025 | marketbeat.comEmpowered Funds LLC Takes $443,000 Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)Empowered Funds LLC purchased a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 1,348 shares of the medical research company's stoFebruary 20, 2025 | marketbeat.comBio-Rad sued by Caltech over DNA analysis technologyFebruary 19, 2025 | reuters.comBio-Rad Laboratories (NYSE:BIO) Downgraded by StockNews.com to "Hold"StockNews.com downgraded Bio-Rad Laboratories from a "buy" rating to a "hold" rating in a report on Monday.February 18, 2025 | marketbeat.comStrategic Financial Concepts LLC Takes $3.56 Million Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)Strategic Financial Concepts LLC purchased a new position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 10,841 shares of the medicalFebruary 17, 2025 | marketbeat.comBio-Rad Laboratories (NYSE:BIO) Sees Unusually-High Trading Volume Following Earnings BeatBio-Rad Laboratories (NYSE:BIO) Sees Large Volume Increase Following Better-Than-Expected EarningsFebruary 15, 2025 | marketbeat.comBio-Rad Laboratories (NYSE:BIO) Posts Quarterly Earnings Results, Beats Expectations By $0.04 EPSBio-Rad Laboratories (NYSE:BIO - Get Free Report) posted its quarterly earnings results on Thursday. The medical research company reported $2.90 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.86 by $0.04. Bio-Rad Laboratories had a negative net margin of 30.18% and a positive return on equity of 3.74%.February 14, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Stake Cut by Allspring Global Investments Holdings LLCAllspring Global Investments Holdings LLC reduced its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 3.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 143,737 shares of tFebruary 14, 2025 | marketbeat.comBio-Rad Laboratories Inc (BIO) Q4 2024 Earnings Call Highlights: Navigating Challenges with ...February 14, 2025 | gurufocus.comQ4 2024 Bio Rad Laboratories Inc Earnings Call TranscriptFebruary 14, 2025 | gurufocus.comBio-Rad Laboratories, Inc. (BIO) Q4 2024 Earnings Call TranscriptFebruary 14, 2025 | seekingalpha.comEarnings call transcript: Bio-Rad Q4 2024 results miss forecastsFebruary 13, 2025 | msn.comBio-Rad Labs stock down 4% as Q4 revenue and guidance miss expectationsFebruary 13, 2025 | msn.comBio-Rad to acquire Stilla TechnologiesFebruary 13, 2025 | markets.businessinsider.comBio-Rad Offers to Acquire Digital PCR Developer Stilla TechnologiesFebruary 13, 2025 | finance.yahoo.comBio-Rad reports Q4 adjusted EPS $2.90, consensus $2.88February 13, 2025 | markets.businessinsider.comBio-Rad set to acquire Stilla TechnologiesFebruary 13, 2025 | msn.comBio-Rad Reports Fourth-Quarter and Full-Year 2024 Financial ResultsFebruary 13, 2025 | businesswire.comVan ECK Associates Corp Has $237.67 Million Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)Van ECK Associates Corp trimmed its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 44.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 723,471 shares of the medical research companFebruary 13, 2025 | marketbeat.comSumitomo Mitsui Trust Group Inc. Decreases Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)Sumitomo Mitsui Trust Group Inc. reduced its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 4.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 36,395 shares of the medical researFebruary 13, 2025 | marketbeat.comBio-Rad price target lowered to $345 from $360 at Wells FargoFebruary 12, 2025 | markets.businessinsider.comBio-Rad Laboratories Inc (BIO) Q4 2024 Earnings Report Preview: What To Look ForFebruary 12, 2025 | finance.yahoo.comWells Fargo & Company Cuts Bio-Rad Laboratories (NYSE:BIO) Price Target to $345.00Wells Fargo & Company decreased their price objective on shares of Bio-Rad Laboratories from $360.00 to $345.00 and set an "equal weight" rating for the company in a report on Wednesday.February 12, 2025 | marketbeat.comBio-Rad Laboratories (NYSE:BIO) Shares Down 4.2% - Here's What HappenedBio-Rad Laboratories (NYSE:BIO) Shares Down 4.2% - What's Next?February 12, 2025 | marketbeat.comEntropy Technologies LP Sells 2,033 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Entropy Technologies LP trimmed its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 48.4% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,167 shares of the medical research company's stock after seFebruary 12, 2025 | marketbeat.comWells Fargo Sticks to Their Hold Rating for Bio-Rad Laboratories (BIO)February 10, 2025 | markets.businessinsider.comStrategic Financial Concepts LLC Invests $3.56 Million in Bio-Rad Laboratories, Inc. (NYSE:BIO)Strategic Financial Concepts LLC purchased a new stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 10,841 shares of the medical research companFebruary 10, 2025 | marketbeat.comQ4 EPS Estimate for Bio-Rad Laboratories Raised by AnalystBio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) - Zacks Research increased their Q4 2024 earnings per share (EPS) estimates for Bio-Rad Laboratories in a report released on Thursday, February 6th. Zacks Research analyst R. Department now anticipates that the medical research company will postFebruary 10, 2025 | marketbeat.comLecap Asset Management Ltd. Invests $510,000 in Bio-Rad Laboratories, Inc. (NYSE:BIO)Lecap Asset Management Ltd. bought a new stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 1,552 shares of the medical research company's stock, valued at approximately $510February 9, 2025 | marketbeat.comBio-Rad Laboratories (BIO) to Release Quarterly Earnings on ThursdayBio-Rad Laboratories (NYSE:BIO) will be releasing earnings after the market closes on Thursday, February 13, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=481392)February 6, 2025 | marketbeat.comRobeco Institutional Asset Management B.V. Sells 2,239 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Robeco Institutional Asset Management B.V. cut its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 22.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,761 shares of the medical research coFebruary 4, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Acquired by DAVENPORT & Co LLCDAVENPORT & Co LLC boosted its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 48.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 84,677 shares of the medical researchFebruary 3, 2025 | marketbeat.comKBC Group NV Has $749,000 Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)KBC Group NV decreased its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 26.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,281 shares of the medical research company'February 3, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Short Interest UpdateBio-Rad Laboratories, Inc. (NYSE:BIO - Get Free Report) was the target of a large increase in short interest in January. As of January 15th, there was short interest totalling 655,500 shares, an increase of 18.8% from the December 31st total of 551,600 shares. Based on an average daily trading volume, of 183,600 shares, the days-to-cover ratio is currently 3.6 days. Currently, 3.4% of the shares of the stock are short sold.February 2, 2025 | marketbeat.com Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter. Email Address BIO Media Mentions By Week BIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIO News Sentiment▼1.040.70▲Average Medical News Sentiment BIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIO Articles This Week▼116▲BIO Articles Average Week Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Mettler-Toledo International News Waters News Illumina News Bio-Techne News Charles River Laboratories International News Bruker News Pacific Biosciences of California News Harvard Bioscience News Thermo Fisher Scientific News Agilent Technologies News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BIO) was last updated on 3/4/2025 by MarketBeat.com Staff From Our Partners77 Hedge Funds Are Betting On This Off-Radar MineralWith surging prices... supply shortages... and growing demand, hedge funds are betting big on potash. In fa...The Tomorrow Investor | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Rad Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIO Stock Alerts